Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
XORTX Therapeutics Inc. (XRTX) had Free Cash Flow per Share of $-3.32 for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
-- |
|
$-2.16M |
|
-- |
|
-- |
|
$6.05M |
|
$-6.05M |
|
$3.89M |
|
$-2.16M |
|
$-2.16M |
|
$-2.16M |
|
$-2.16M |
|
$-2.16M |
|
$-2.16M |
|
$-6.05M |
|
$-5.91M |
|
1.98M |
|
1.98M |
|
$-1.09 |
|
$-1.09 |
|
| Balance Sheet Financials | |
$4.07M |
|
$0.02M |
|
$1.40M |
|
$5.47M |
|
$0.29M |
|
-- |
|
$0.53M |
|
$0.83M |
|
$4.64M |
|
$4.47M |
|
$4.64M |
|
2.00M |
|
| Cash Flow Statement Financials | |
$-6.58M |
|
$-0.05M |
|
$-0.36M |
|
$10.43M |
|
$3.45M |
|
$-6.99M |
|
$0.12M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.80 |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.59M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-46.49% |
|
-48.31% |
|
-39.47% |
|
-46.49% |
|
$2.32 |
|
|
Free Cash Flow per Share |
$-3.32 |
$-3.32 |
|